Valuation: Demant A/S

Capitalization 50.36B 7.83B 6.74B 6.17B 5.83B 10.77B 757B 10.94B 73.12B 28.61B 357B 29.4B 28.78B 1,244B P/E ratio 2026 *
19.9x
P/E ratio 2027 * 16.2x
Enterprise value 67.59B 10.52B 9.04B 8.28B 7.82B 14.45B 1,016B 14.68B 98.13B 38.4B 479B 39.46B 38.63B 1,670B EV / Sales 2026 *
2.62x
EV / Sales 2027 * 2.41x
Free-Float
39.73%
Yield 2026 *
-
Yield 2027 * -
1 day+0.84%
1 week+3.89%
Current month+19.01%
1 month+8.68%
3 months+33.85%
6 months+11.92%
Current year+11.71%
1 week 226.2
Extreme 226.2
244.2
1 month 194.4
Extreme 194.4
244.2
Current year 175
Extreme 175
244.2
1 year 175
Extreme 175
293
3 years 175
Extreme 175
373.5
5 years 167.5
Extreme 167.5
394.7
10 years 108.1
Extreme 108.1
394.7
Manager TitleAgeSince
Chief Executive Officer 55 01/04/2017
Director of Finance/CFO 53 01/09/2015
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 68 01/04/2017
Chairman 56 05/03/2026
Director/Board Member 59 01/01/2021
Change 5d. change 1-year change 3-years change Capi.($)
+0.88%+3.89%-10.70%-17.22% 7.83B
-0.73%+3.37%-34.04%-18.93% 154B
-0.60%+1.03%-7.88%-13.12% 100B
+0.30%-3.94%+50.94%+63.57% 55.82B
-0.19%+1.34%-9.18%+53.63% 51.51B
-0.95%+0.78%-15.91%-42.00% 40.49B
+0.80%-6.20% - - 30.65B
-0.41%+24.02%-15.53%-39.89% 27.57B
+1.36%+2.97%+47.94%-11.91% 21.58B
-0.45%+20.83%-13.49%+10.03% 21.76B
Average -0.00%+4.36%-0.87%-1.76% 51.15B
Weighted average by Cap. -0.32%+3.75%-8.47%-1.86%

Financials

2026 *2027 *
Net sales 25.78B 4.01B 3.45B 3.16B 2.98B 5.51B 387B 5.6B 37.43B 14.65B 183B 15.05B 14.73B 637B 27.44B 4.27B 3.67B 3.36B 3.17B 5.87B 412B 5.96B 39.83B 15.59B 195B 16.02B 15.68B 678B
Net income 2.54B 395M 340M 311M 294M 543M 38.19B 552M 3.69B 1.44B 18.03B 1.48B 1.45B 62.79B 3.09B 481M 414M 379M 358M 661M 46.48B 672M 4.49B 1.76B 21.94B 1.81B 1.77B 76.43B
Net Debt 17.23B 2.68B 2.31B 2.11B 1.99B 3.68B 259B 3.74B 25.02B 9.79B 122B 10.06B 9.85B 426B 15.74B 2.45B 2.11B 1.93B 1.82B 3.37B 237B 3.42B 22.86B 8.94B 112B 9.19B 9B 389B
Logo Demant A/S
Demant A/S is the world's 2nd leading producer of audio products. Net sales break down by family of products as follows: - hearing care products (46.7%): sold in clinics under the brands Audika, HearingLife, Hidden Hearing and Acústica Médica; - tailor-made hearing aids (42.8%): hearing aid and audiphones sold under the Oticon, Bernafon, Philips and Sonic brands; - diagnostic products (10.5%): audiometers sold under the brands Maico, Interacoustics, amplivox, gsi, MedRx and audioscan. Net sales are distributed geographically as follows: Denmark (1.5%), Europe (40.2%), the United States (32%), North America (6.7%), Asia (9.1%), Pacific (4.7%) and other (3%).
Employees
25,077
Date Price Change Volume
21/05/26 240.40 kr +0.67% 129,428
20/05/26 238.80 kr +4.65% 490,821
19/05/26 228.20 kr -1.38% 452,903
18/05/26 231.40 kr -1.87% 516,204
13/05/26 235.80 kr -0.84% 458,154
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
238.80DKK
Average target price
240.32DKK
Spread / Average Target
+0.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. DEMANT Stock